Plain-English translation of NCT05388461 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Depressive Disorder research guide →This study is following people who receive electroconvulsive therapy (ECT) — a medical procedure that uses controlled electrical stimulation to help treat severe depression. Researchers want to understand how well this treatment works, how long any side effects last, and what factors help predict whether someone will improve or relapse after treatment.
Some people with severe depression don't respond well to medications alone. This treatment can help, but doctors need better information about which patients benefit most, how long recovery takes, and what happens in the months after treatment to prevent depression from coming back.
You likely qualify if…
You likely don't qualify if…
You'll be enrolled in a research registry after you receive your electroconvulsive therapy treatment. Researchers will measure your depression symptoms and how well your thinking and memory are working right after treatment and then again at 6 months. This involves completing questionnaires and assessments that your care team will administer — you won't need to take any additional medications or make extra visits just for the research.
AI-generated summary from trial data · Jun 26, 2026 · Not medical advice
Norway
Sponsor
Haukeland University Hospital
Collaborators
Helse Stavanger HF
Enrollment target
~600 participants
Started
March 2013
Primary completion
December 2028
Age range
18 Years and older
Last updated on clinicaltrials.gov in September 2023.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Ute Kessler, PhD
Haukeland University Hospital
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.